USA - NASDAQ:CALA - US13089P5070 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to CALA. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-15 | Ladenburg Thalmann | Downgrade | Buy -> Neutral |
| 2022-11-15 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-08-29 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2022-08-16 | SVB Leerink | Maintains | Outperform |
| 2022-05-11 | Wells Fargo | Maintains | Equal-Weight |
| 2022-01-31 | Ladenburg Thalmann | Initiate | Buy |
| 2022-01-20 | SVB Leerink | Upgrade | Market Perform -> Outperform |
| 2021-11-08 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2021-11-05 | William Blair | Downgrade | Outperform -> Market Perform |
10 analysts have analysed CALA and the average price target is 5.1 USD. This implies a price increase of 1296.88% is expected in the next year compared to the current price of 0.3651.
The consensus rating for CALITHERA BIOSCIENCES INC (CALA) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.